Survival pathway of cholangiocarcinoma via AKT/mTOR signaling to escape RAF/MEK/
- This topic has 0 replies, 1 voice, and was last updated 6 years, 4 months ago by
.
Viewing 1 post (of 1 total)
-
Posts
-
Survival pathway of cholangiocarcinoma via AKT/mTOR signaling to escape RAF/MEK/ERK pathway inhibition by sorafenib
https://www.ncbi.nlm.nih.gov/pubmed/29251327
Viewing 1 post (of 1 total)
- The forum ‘Chemotherapy & More’ is closed to new topics and replies.